From Stigma to Salvation: The Psychedelic Renaissance in Trauma Therapy
If you grew up in the 1960s or 70s, or even if you just watched movies from that era, the word “psychedelic” probably conjures up some very specific images. You might picture tie-dye shirts, Woodstock, counterculture protests, or the chaotic LSD trips depicted in films like Easy Rider or The Trip. For decades, psychedelics were firmly boxed into the category of dangerous, unpredictable street drugs, a stigma fueled by political agendas and sensationalized media.
But today, we are witnessing a profound cultural and medical shift. The very substances once dismissed as relics of a rebellious generation are now at the forefront of a mental health revolution. We are moving past the stigma and discovering that, when used in a controlled, clinical setting, psychedelic-assisted therapy is offering unprecedented hope for people struggling with treatment-resistant conditions, particularly severe trauma and PTSD.
The Invisible Wounds of War
Nowhere is this shift more evident, and more urgently needed, than within our veteran community. When we think of the psychological toll of combat, many of us recall the heartbreaking portrayal of Lieutenant Dan in Forrest Gump. Returning from Vietnam having lost his legs, he was consumed by anger, alcoholism, and profound despair. He was a man drowning in trauma, isolated from a society that didn’t know how to help him.
Tragically, that fictional portrayal mirrors a very real, ongoing crisis. According to the Department of Veterans Affairs’ 2025 National Veteran Suicide Prevention Annual Report, an average of 17.5 veterans die by suicide every single day. Some organizations estimate that number could be even higher. Veterans are over 57% more likely to die by suicide than non-veterans. They return home facing immense struggles; not just the haunting memories of combat, but the devastating ripple effects: the loss of families, the inability to hold down jobs, and the deterioration of their physical and mental health.
Traditional therapies and medications work for many, but not for all. Research shows that nearly 26% of U.S. service members and veterans drop out of standard PTSD therapy, and about a third of all PTSD patients are considered “treatment-resistant.” For these individuals, the standard tools simply aren’t enough. They are left feeling trapped in their own minds, much like Lieutenant Dan before he finally made his peace.
A New Kind of Mission: Healing Across Borders
Faced with these grim statistics and a lack of effective options at home, many veterans have taken matters into their own hands. This desperate search for healing is powerfully chronicled in the 2025 Netflix documentary In Waves and War. The film follows former U.S. Navy SEALs, including Marcus Capone and DJ Shipley, who hit rock bottom after returning to civilian life.
Unable to find relief through traditional medicine, these elite warriors traveled to clinics in Mexico to undergo treatment with Ibogaine, a powerful psychedelic derived from a Central African shrub. Because Ibogaine remains illegal in the United States, these veterans had to cross borders to access a treatment that ultimately saved their lives. Stanford researchers followed their progress, and the results were remarkable.
The documentary captures their profound transformations. As one veteran, Joe, expressed after his treatment: “There’s a light in my eye that I haven’t seen since I was a child.” Another veteran, Matty Roberts, told his therapist six months later: “If I go into a dark place, now instead of being in it as a captive, I’m in it as an observer. It doesn’t have to trap me anymore.”
Marcus Capone, who co-founded Veterans Exploring Treatment Solutions (VETS) to fund veterans seeking psychedelic treatments abroad, put it beautifully: “It gives you a new white canvas to paint whatever you want on there, but you have to put plans in place otherwise you potentially can go back.”
The Science Backing the Shift
This isn’t just anecdotal evidence from a documentary; rigorous scientific research is backing up these incredible stories of recovery. A 2025 study published in Nature by Stanford Medicine researchers followed 30 special operations veterans who received Ibogaine treatment. The results were staggering: the treatment significantly reduced symptoms of PTSD, anxiety, and depression, and improved overall functioning, even in veterans with traumatic brain injuries.
While Ibogaine is still being studied and is not available in the U.S., another powerful tool is already accessible and making waves: Ketamine-Assisted Psychotherapy (KAP). Originally developed as an anesthetic, ketamine has proven to be a rapid-acting and highly effective treatment for severe depression and PTSD.
A landmark 2021 study by researchers at Mount Sinai found that repeated intravenous ketamine infusions significantly reduced symptom severity in individuals with chronic PTSD. Similarly, a 2023 study published in the New England Journal of Medicine demonstrated that 55% of patients with treatment-resistant depression experienced at least a 50% improvement after receiving ketamine therapy. Furthermore, a 2024 study from Michigan Medicine showed that after just three ketamine infusions over 11 days, 52% of participants achieved remission from severe depression.
Another Tool in the Toolbelt
As a trauma therapist specializing in EMDR, IFS, and KAP, I view psychedelic-assisted therapy not as a magic cure-all, but as a vital, powerful addition to our clinical toolbelt. It is important to acknowledge that KAP is not for everyone. There are specific medical and mental health contraindications, such as certain heart conditions or a history of active psychosis, that must be carefully evaluated by a medical professional before beginning treatment.
However, for those who are appropriate candidates, KAP can be the key that unlocks the door to healing. It can quiet the brain’s default mode network, allowing patients to process deeply entrenched trauma without being overwhelmed by the paralyzing fear and anxiety that usually accompany those memories. It provides that “new white canvas” Marcus Capone spoke of – a chance to reset and rebuild.
We have come a long way from the stigma of the 1960s. Today, we understand that these medicines, when combined with professional psychotherapy, offer a lifeline to those who have been suffering in the dark for far too long. Whether it’s a veteran fighting the invisible wounds of war or an individual battling lifelong, treatment-resistant depression, there is hope. The psychedelic renaissance is here, and it is saving lives.
Curious About KAP?
Schedule a free, no-obligation screening to see if Ketamine-Assisted Psychotherapy is right for you.
Schedule a Free ScreeningSources:
U.S. Department of Veterans Affairs, 2025 National Veteran Suicide Prevention Annual Report
Feder, A. et al. (2021). A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic PTSD. American Journal of Psychiatry
Brendle, M. et al. (2023). Ketamine Found Effective in Treatment-Resistant Depression. New England Journal of Medicine
Almeida, T.M. et al. (2024). Effectiveness of Ketamine for the Treatment of PTSD. Clinical Psychopharmacology and Neuroscience
Stanford Medicine/Nature (2025). Ibogaine + Magnesium Study in Special Operations Veterans
TIME Magazine (2025). “The Gripping Story Behind Netflix’s In Waves and War”
Warmly,
Heleen Woest, MA, LPC, NCC
EMDR Certified | Trauma Treatment Certified | KAP Certified | IFS Certified
